Undifferentiated Pleomorphic Sarcoma and the Importance of Considering the Oncogenic and Immune-Suppressant Role of the Human T-Cell Lymphotropic Virus Type 1: A Case Report
IntroductionSoft-tissue sarcomas account for 0.7% of all malignant tumors, with an incidence rate of 3 per 100,000 persons/year. The undifferentiated pleomorphic sarcoma (UPS) with giant cells, a high grade tumor of soft tissue, is very unusual, especially in young adults before the age of 40. Human...
Main Authors: | Sergio Lupo, Carolina Berini, Camila Cánepa, Eduardo Santini Araujo, Mirna Biglione |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fonc.2017.00091/full |
Similar Items
-
Undifferentiated pleomorphic sarcoma: Diagnosis of exclusion
by: Pragati S. Upasham, et al.
Published: (2017-07-01) -
Undifferentiated pleomorphic sarcoma of the prostate in a young man
by: Yuya Iwahashi, et al.
Published: (2020-07-01) -
Undifferentiated pleomorphic sarcoma of the mammary gland
by: Javier Martínez-Navarro, et al.
Published: (2019-05-01) -
Head and Neck Tumors: Management of Primary Undifferentiated Pleomorphic Sarcoma
by: Luis-Alejandro Boccalatte, et al.
Published: (2019-11-01) -
Primary pulmonary undifferentiated pleomorphic sarcoma (PPUPS)
by: Amir Qorbani, et al.
Published: (2019-07-01)